Published on 21/12/2025
Comprehensive Guide to Site Initiation Visit (SIV) Checklist and Objectives
The Site Initiation Visit (SIV) marks a critical milestone in the clinical trial start-up process. It signals that a site is ready to begin patient enrollment and that all staff are trained and equipped for protocol adherence and GCP compliance. In this tutorial, we walk through the essential components of the SIV—what it aims to achieve, how to prepare, and what to include in your checklist to ensure a successful site activation.
What is a Site Initiation Visit (SIV)?
An SIV is a formal meeting between the sponsor or CRO and the investigational site team conducted after regulatory approvals are in place but before the site begins enrolling subjects.
- Confirms site readiness for trial initiation
- Ensures all study staff are trained on protocol and procedures
- Verifies essential documents, equipment, and IMP availability
- Resolves any final site queries before activation
Primary Objectives of the SIV:
- Provide comprehensive training on the protocol and investigational product
- Ensure understanding of GCP obligations and reporting requirements
- Verify document completeness and regulatory binder setup
- Confirm site logistics and delegation of responsibilities
- Finalize pre-FPI (First Patient In) readiness
SIVs are also a compliance checkpoint and often reviewed during sponsor or USFDA audits.
Pre-SIV Preparation Steps:
- Send agenda and checklist to
Using an SIV-specific SOP and templates from Pharma SOPs standardizes the process.
Detailed SIV Checklist:
A thorough checklist ensures consistency and completeness. Categories to include:
1. Protocol Training:
- Study design, objectives, endpoints, and procedures
- Inclusion/exclusion criteria with examples
- Visit schedule and allowable windows
- Randomization and blinding procedures (if applicable)
2. Investigational Product (IP) and Accountability:
- Storage requirements (temperature logs, security)
- IP receipt, verification, and accountability log
- Instructions for dispensing and return of unused product
- Review of pharmacy procedures and unblinding process
3. Regulatory Documents and IRB Approval:
- Signed protocol and ICF approvals
- Updated CVs, GCP certificates, medical licenses
- Financial disclosure forms
- Completed 1572 or equivalent forms
4. Safety and AE/SAE Reporting:
- Definitions of adverse events and serious adverse events
- Reporting timelines and contact points
- Emergency unblinding protocol
- Safety monitoring committee interactions (if applicable)
5. Source Documentation and Data Entry:
- Source documentation expectations
- Electronic Case Report Form (eCRF) training and demo
- Query resolution process
- Audit trail maintenance and version control
6. Delegation of Authority and Staff Roles:
- Review of site staff and delegated responsibilities
- Staff sign-off on protocol and SOPs
- Contingency planning for staff turnover
7. Site Logistics and Equipment:
- Tour of facility (if in-person)
- Review of lab equipment, centrifuge, storage, and shipping supplies
- IMP access control and calibration records
During the SIV Meeting:
Ensure active participation by:
- Principal Investigator (PI)
- Sub-Investigators and Clinical Research Coordinators
- Pharmacist (if IP is managed onsite)
- Laboratory contact (if site-managed lab is used)
Use a sign-in sheet to document attendance for audit purposes.
Post-SIV Follow-Up:
- Share a completed SIV checklist with site and project team
- Issue a greenlight letter for activation once all conditions are met
- Address outstanding action items, such as missing documents or unresolved queries
- Update CTMS and TMF with finalized materials
Common Pitfalls to Avoid:
- Insufficient training or rushed protocol review
- Incomplete regulatory binder or missing signatures
- Failure to test EDC logins or confirm access
- IMP not delivered or stored improperly
Conclusion:
The Site Initiation Visit is a vital milestone that ensures trial quality from the outset. By using a structured checklist, defining clear objectives, and involving all key personnel, sponsors and CROs can confidently activate sites with full regulatory compliance. Tools and SOP templates from Stability Studies can further streamline your SIV process and documentation workflows.